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A B S T R A C T
Background: Mucormycosis is a rare but life-threatening infection, caused by fungi of the
Mucorales order, which can be found in soil, rotting leaves or on animals. Through characteristic
angioinvasive growth, infections with mucor spores can occur as a pulmonary, rhinocerebral or
cutaneous form. Infections mainly affect immunosuppressed patients with a history of un-
controlled diabetes or haematological malignancies, among others. Treatment is multimodal and
requires an immediate combination of intravenous amphotericin B therapy and serial surgical
debridements. Only a limited number of cases of cutaneous mucormycosis of the hand have been
documented and described previously.
Case presentation: We report a cutaneous mucormycosis in an elderly patient with a therapy-
resistant acute myeloid leukaemia after a minor trauma on his right hand, sustained whilst
gardening. The fungal infection was treated with serial radical debridements, vacuum-assisted
negative-pressure wound closure technique and intravenous antifungals. Despite successful
eradication of the fungal infection, a palliative open wound care concept was implemented
during the terminal course of the patient's leukaemia.
Conclusions: Cutaneous mucormycosis is a rare but fulminant fungal infection mostly affecting
immunosuppressed patients. Survival is possible when diagnosed and treated early, yet mortality
rates remain high.
Background
Mucormycosis is an invasive and rapidly progressing fungal infection caused by Mucorales organisms of the Zygomycota family.
The ubiquitous filamentous fungi (molds) are frequently present in soil, decaying plants and on animals. More than 200 species
belong to the Mucorales order, including Sporodiniella, Syzygites, and Rhizopus of the Rhizopodaceae family [1]. Mucormycosis pre-
dominantly affects immunosuppressed patients suffering from haematological malignancies, advanced human immunodeficiency
virus (HIV) infection or uncontrolled diabetes mellitus. Infections include pulmonary, rhinocerebral, cutaneous or disseminated
manifestations. First-line treatment consists of intravenous antifungal therapy with liposomal amphotericin B and radical surgical
debridement. High morbidity and mortality are related to the high virulence of the fungus, its resistance to innate host defence and its
angioinvasive growth, which leads to tissue necrosis and haematogenous dissemination [2]. The median time from first symptoms to
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diagnosis is two weeks, and mortality rates range from 22% in the cutaneous to 79% in the disseminated form [3].
Case presentation
We report the case of a 78-year old patient who presented to our surgical emergency department with swelling, erythema and
pain of the back of his right hand, accompanied by a progressing hematoma located between the third and fourth metacarpopha-
langeal joint (Fig. 1A). First signs of erythema and swelling manifested three days earlier, after a minor laceration, inflicted whilst
gardening. Local incision and debridement were performed in another hospital and the patient was referred to our hospital because of
progressive signs and symptoms of a local infection. The patient was previously diagnosed with a therapy-resistant acute myeloid
leukaemia (AML) (46, XY, del(20)(q11.2)(18)/46, XY(3)) for which he received platelet and erythrocyte concentrates on a weekly
basis. AML was diagnosed ten months earlier as a transformation from a known myelodysplastic syndrome.
Upon admission, the patient's C-reactive protein (CrP) level was increased at 41.6 mg/l [< 5mg/l], his leukocyte count was 3.47/
nl [normal range, 3.90–10.50/nl] and his thrombocyte count was 17/nl [normal range, 150–300/nl]. After wound inspection, sterile
wound dressings were applied, the patient's forearm and hand were immobilized in a cast, and treatment with intravenous ampicillin
and sulbactam was initiated. At this time no indication for surgery was given, as clinical findings were consistent with a localized
superficial infection. Within the next 12 h however, clinical symptoms worsened, and the antibiotic strategy was changed to pi-
peracillin-tazobactam combined with clindamycin. Under the assumption of a progressive phlegmon of the hand at post-admission
day (PAD) one, the patient underwent surgery. A thorough debridement and wound irrigation, via a dorsal incision, were performed.
At the same time multiple samples for microbiological and histological analyses were harvested. Primary wound closure with two
drains was achieved (Fig. 1B).
On PAD three, local swelling and infectious parameters increased (CrP of 159.6mg/l, leukocyte count of 4.78/nl), and revision
surgery was performed on PAD four (Fig. 1C). One day later, microbiological results from the first surgery revealed an infection with
Rhizopus species (spp.) and thus the diagnosis of a cutaneous mucormycosis was confirmed. Intravenous amphotericin B treatment was
initiated immediately and further debridements were planned. In addition, growth of Staphylococcus epidermidis was observed in the
same samples and clindamycin was stopped. Histopathologic analysis followed and showed proof of angioinvasive mucormycosis
(Fig. 4). On PAD six, a second revision surgery was performed due to progressing local skin necrosis (Fig. 2A). A computed tomo-
graphy scan of the thorax and abdomen on PAD seven, revealed suspicious lymph nodes of the mediastinum, but acquired biopsies
showed no signs of a pulmonary fungal infection. The following day (PAD eight), the patient received a third revision operation
(Fig. 2B) with the application of vacuum-assisted negative-pressure wound closure technique (Fig. 2C). Intraoperatively collected
tissue samples showed remaining fungal hyphae and Staphylococcus epidermidis in three specimens and intravenous vancomycin was
added. All tissue samples harvested from subsequent revision surgeries (PAD 10, 14, 17 and 21) did not show any further fungal or
bacterial growth.
Fig. 1. PAD zero, initial clinical presentation in emergency department (A). PAD one, first surgery, postoperative finding (B). PAD four, first revision
surgery, intraoperative finding prior to debridement (C).
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Granulation tissue formation was observed from PAD 10 onwards, following further elective revision surgery (Fig. 3A). On PAD
11 the patient's respiratory function decreased rapidly, and extensive bilateral pleural effusions were observed on chest x-rays. The
patient was transferred to the intensive care unit and two thorax-drains were placed for therapeutic thoracentesis, upon which the
patient's respiratory function improved. However, his general condition worsened notably over the following days, despite the fact
that further revision surgeries revealed clean and vital wound conditions on PAD 14 (Fig. 3B), 17 and 21 (Fig. 3C).
Fig. 4. Periodic acid–Schiff stained sections showing angioinvasive growth of Rhizopus spp. at a magnification of 200 (A) and 400 (B). M: mu-
cormycosis, V: blood vessel.
Fig. 2. PAD six, second revision surgery, intraoperative finding during debridement (A). PAD eight, third revision surgery, intraoperative finding
prior to debridement and application of a vacuum-assisted negative-pressure wound closure technique (B). PAD eight, third revision surgery,
postoperative finding after application of vacuum-assisted negative-pressure wound closure technique (C).
Fig. 3. PAD 10, fourth revision surgery, preoperative finding with beginning granulation tissue formation (A). PAD 14, fifth revision surgery,
preoperative finding (B). PAD 21, seventh revision surgery, preoperative finding (C). PAD 31, five days after removal of extensor tendons on PAD 25
(D).
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At this stage, the patient and his relatives decided to decline further curative surgeries due to the underlying comorbidity and his
general condition. In accordance with the patient's will, we removed the exposed extensor-tendons of the hand on PAD 25 as a
palliative approach, allowing further soft-tissue granulation without further surgery. Fig. 3D shows a postoperative picture on PAD
31, six days after removal of the extensor tendons. At this point, the patient's general condition worsened further, and signs of
pulmonary exhaustion and delirium were evident. On PAD 33 the patient died in the presence of his relatives due to his underlying
condition.
Discussion and conclusions
Cutaneous mucormycosis of the hand is rarely reported and amputation of the hand and death are common complications of this
fulminant fungal infection [4–6]. The fungal infection is caused by members of the Mucorales order, which consists of mostly sa-
protrophic organisms [1]. Cutaneous mucormycosis manifests predominantly in immunocompromised patients following minor
trauma due to direct spore inoculation of exposed wounds. Risk factors include hematologic disorders, diabetes mellitus, gluco-
corticoid therapy, intravenous drug abuse, renal failure and neutropenia [5]. Yet, infections with Rhizopus spp. of the hand and foot
have also been reported in immunocompetent patients [5,7]. The described case herein demonstrates a progressive cutaneous
manifestation of Rhizopus mucormycosis after a minor laceration sustained whilst gardening, in a highly immunocompromised pa-
tient with a therapy-resistant AML.
The time between first local symptoms and diagnosis of mucormycosis has been reported to be around two weeks by Lanternier
et al. [3]. In our case, Rhizopus mucormycosis was diagnosed nine days after the patient's first symptoms occurred. Rhizopus spp. is a
mold, found predominantly in soil and decaying plants, which fits well with the patient's history of gardening, before first symptoms
occurred [1].
Diagnosis of cutaneous mucormycosis can be difficult as initial symptoms are often non-specific and can mimic a variety of
infectious skin diseases. This underlines the utmost importance of early harvesting of soft-tissue probes from the lesion site in cases of
progressive signs of infection. Following the guidelines [8], intravenous administration of liposomal amphotericin B and radical
surgical debridement were started immediately upon the diagnosis of suspected mucormycosis. Surgical care included the application
of a vacuum-assisted negative-pressure wound closure technique to cover the soft-tissue defect and to enhance soft-tissue granulation.
This therapy has successfully been used previously to obtain a clean wound with granulating tissue in cutaneous mucormycosis [9].
Fungal hyphae were found until PAD 8 in the intraoperatively collected tissue samples. However, all further biopsies revealed sterile
specimen, indicating successful treatment.
Bearing the patient's underlying condition and the stress of repetitive surgeries in mind, his decision to decline any further
surgical interventions was accepted, and a palliative solution was chosen together with the patient and his relatives. As further
operations, including a potential skin graft transfer or partial amputation, were abandoned, resection of the extensor tendons of the
hand and open wound care were agreed to. Tendons represent a bradytrophic, poorly vascularized tissue with little healing quality
due to avascular superficial zones, which are mainly nourished by diffusion [10]. In order to implement a feasible open wound care
concept, removal of tendons was inevitable and agreed to by the patient.
If the patient had continued treatment and the wound had shown progressing granulation, a muscle flap transfer or skin graft
transfer would have been a possible surgical solution to cover the excessive skin and soft-tissue defect. This was reported previously
as a successful treatment option in a case of cutaneous mucormycosis of the forearm with extensive soft-tissue defects due to radical
surgical debridement [4]. If necrosis had progressed, a full or partial amputation of the hand would have been advised, as previously
described by Lidor et al. in a case report of cutaneous Rhizopus oryzae mucormycosis after a burn injury [11].
The aggressive course of the fungal infection presented here displays that, in spite of early diagnosis, a clear treatment algorithm
is absolutely crucial to reach clinical and paraclinical improvements and to potentially achieve survival or limb salvage in patients
suffering from cutaneous mucormycosis. However, in immunosuppressed patients suffering from diseases like AML or HIV infection
the general condition is often poor. Manifestation of mucormycosis usually appears at a late or terminal stage of the underlying
disease and a fatal course may often not be possible to abrogate, regardless of early diagnosis and successful mucormycosis treatment
[12,13]. Hence, a high level of suspicion for mucormycosis infections should be maintained in immunocompromised patients with
cutaneous infections of any kind. Early sample harvesting for microbiological diagnosis, radical surgical debridement and in-
travenous antifungal therapy are crucial for eradication of mucormycosis and patient recovery.
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